CD1C and cancer: InfDCs (CD14+ CD16− BDCA1+) in cancer ascites were separated from macrophages (CD14+ CD16c+ BDCA1−) and then further characterized for the expression of additional markers (CD11c+ CD11b+ HLA-DR+ BDCA1+ CD206+).